Study Finds Promising Chemoradiation Therapy

	Tweet

Advanced cancer in the head and neck is traditionally treated with surgery followed by radiotherapy. Surgery usually entails removal of areas like the voice box, or part of the throat, leading to speaking and swallowing problems. Because of these side effects, many patients refuse surgery.

In a study to be presented at the 2007 AAO-HNSF Annual Meeting & OTO EXPO, a novel treatment for chemoradiation, using the generic drug Paclitaxel in conjunction with radiotherapy, has shown superior results to other anticancer drugs used in chemoradiation with fewer side effects.

The study comprised 94 previously untreated patients with cancer of the head and neck (stages 3 and 4) who were treated with concomitant chemoradiation over a three-year period (2003-2005) in a medical college hospital. The patients were divided into two groups, with one group receiving concomitant chemotherapy (CT) with Paclitaxel, while the other group received concomitant chemotherapy with Cisplatin. In each group, six cycles of chemotherapy were given on a weekly basis. Results indicate that Paclitaxel is associated with better locoregional control of the cancer at the end of 1 year. However, long term follow up did not reveal significant differences in locoregional control and overall survival in the two groups.

Findings from the study may lead to more effective treatments for head and neck cancer for patients who are unwilling or unable to undergo surgery, and in areas where hospitals do not have the proper facilities to perform traditional chemoradiation treatments.

Title: Chemoradiation in Advanced Head and Neck Cancers
Authors: Sohit Paul Kanotra, Ashutosh Gupta, Sonika Kanotra, Jitender Paul Kanotra.
Date: Sunday, September 16, 10:32 am - 10:40 am

Information for the Media
The AAO-HNS Annual Meeting newsroom will be located in Registration East, Street Level of the Washington, DC Convention Center. Hours of operation: Saturday, September 15, 12 pm to 5 pm; Sunday - Tuesday, September 16 -18, 7:30 am to 5 pm; and Wednesday, September 19, 7:30 am to 2 pm. The newsroom serves as a work space for credentialed members of the media and credentialed public relations staff. The newsroom is managed and staffed by the AAO-HNS Communications Unit.

Source: American Academy of Otolaryngology Head and Neck Surgery (AAOHNS)

RELATED STORIES:
Tooth Loss Linked to Esophageal, Head and Neck, and Lung Cancer   Cancer Researcher Offer New Hope for Brain Tumor   Dana-Farber Hosting Live Twitter Chat on Head and Neck Cancers   Study Compares Treatment Options for Patients with Brain Metastases   HK surgeons upbeat on brain cancer removal method   Researchers Identify Genetic Markers for Aggressive Head and Neck Cancer   Venom protein may lead to brain cancer cure   Some brain tumors mimic the genetic program of germline cells   Blood Pressure Compound May Benefit Brain Tumor Patients   Vaccine against deadly brain cancer shows promise   BNCT, a new-generation radiation treatment, is effective in advanced head and neck cancer   Protein Expression Holds Promise for Head and Neck Cancer Detection   Disparities among patients with extremity soft-tissue sarcomas   New Protocol Targets Aggressive Brain Cancer   Study finds 231 new genes associated with head and neck cancer   Early detection critical in treating pediatric thyroid cancer   Tobacco use linked to worse outcomes in HPV-positive head and neck cancer, U-M study finds   Target for Therapeutic Drugs to Fight Most Common Adult Brain Cancer   High dosage brachytherapy obtains excellent results in head and neck tumors   Do cell phones increase brain cancer risk?   Sex virus blamed for rise in head and neck cancers   Does Green Tea Prevent Cancer? Evidence Continues to Brew, But Questions Remain

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]